Pier Capital’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-415,906	Closed	-$3.7M	–	130
2025 Q3	$3.7M	Sell	415,906 -8,242	-2%	-$83.6K	0.58%	85
2025 Q2	$3.91M	Sell	424,148 -31,279	-7%	-$267K	0.6%	80
2025 Q1	$3.91M	Buy	455,427 +13,512	+3%	+$128K	0.65%	74
2024 Q4	$4.75M	Buy	+441,915	New	+$3.4M	0.68%	80
2023 Q1	–	Sell	-280,854	Closed	-$2.6M	–	110
2022 Q4	$2.6M	Sell	280,854 -103,957	-27%	-$1.11M	0.43%	91
2022 Q3	$3.97M	Buy	384,811 +632	+0.2%	+$6.67K	0.68%	73
2022 Q2	$3.85M	Sell	384,179 -104,515	-21%	-$990K	0.66%	73
2022 Q1	$6.02M	Buy	488,694 +212,350	+77%	+$2.61M	0.77%	74
2021 Q4	$4.79M	Buy	276,344 +161	+0.1%	+$3.06K	0.51%	89
2021 Q3	$4.96M	Buy	+276,183	New	+$5.5M	0.51%	93